36 research outputs found

    Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort

    No full text
    Occupational lung cancers are under-reported and under-compensated worldwide. We assessed systematic screening for occupational exposure to carcinogens combining a self-administered questionnaire and an occupational consultation to improve the detection of occupational lung cancers and their compensation. Social deprivation and the costs of this investigation were estimated. Patients with lung cancer received a self-administered questionnaire to collect their job history, potential exposure to carcinogens and deprivation. A physician assessed the questionnaire and recommended an occupational consultation if necessary. During the consultation, a physician assessed if the lung cancer was work-related and, if it was, delivered a medical certificate to claim for compensation. Over 18 months, 440 patients received the self-administered questionnaire: 234 returned a completed questionnaire and a consultation was required for 120 patients. Compensation was judged possible for 41 patients. Among the 35 medical certificates delivered, 19 patients received compensation. Nearly half the patients (46%) were assessed as socially deprived and these patients took significantly longer to return the questionnaire compared with those who were not deprived. The mean cost of the process was €62.65 per patient. Our results showed a systematic self-administered questionnaire can be used to identify patients potentially exposed to carcinogens and to improve compensation

    Expositions professionnelles et cancer du poumon : démarche de repérage systématique des expositions professionnelles pour améliorer la reconnaissance en maladie professionnelle, association avec la survie

    No full text
    About 15% of lung cancers are attributable to occupational exposures. Yet, occupational cancers remain largely under-reported and under-recognized. The aim of this thesis was to implement and evaluate a systematic screening of occupational exposures as well as its reproducibility and to assess the association between occupational exposure to asbestos and survival in lung cancer patients. The PROPOUMON study validated a self-administered questionnaire for the detection of occupational exposures and confirmed the feasibility of the screening process, with an average cost of 62 euros/patient. The study confirmed the frequency of lung cancers attributable to occupational exposures (18%). The ancillary study highlighted the role that the oncologist could play in the patient's adherence to the process. The national PROPOUMON study confirmed the reproducibility of the process in other hospitals and its efficiency in detecting occupational exposures. Our data suggested an impact of occupational asbestos exposure on survival, although the results were not significant. This thesis work assessed a process for systematically screening lung cancer patients for occupational exposures that could be integrated into the care pathway. Further work is needed to increase patients’ adherence to the process. A consideration of its funding is important to maintain its sustainability. The potential role of occupational exposures on cancer prognosis strengthens the need for a systematic screening.Environ 15% des cancers du poumon seraient attribuables aux expositions professionnelles. Cependant, ces cancers d’origine professionnelle restent largement sous-dĂ©clarĂ©s et sous-reconnus. Ce travail de thĂšse avait pour objectif de mettre en place et d’évaluer une dĂ©marche de repĂ©rage systĂ©matique des expositions professionnelles ainsi que sa reproductibilitĂ© et d’évaluer l’association entre l’exposition professionnelle Ă  l’amiante et la survie chez les patients atteints d’un cancer du poumon. L’étude PROPOUMON a permis de valider un auto-questionnaire de repĂ©rage des expositions professionnelles et de confirmer la faisabilitĂ© de la dĂ©marche de repĂ©rage, dont le coĂ»t moyen est de 62 euros/patient. L’étude a confirmĂ© la frĂ©quence des cancers du poumon liĂ©s aux expositions professionnelles (18%). L’étude ancillaire a montrĂ© le rĂŽle que pourrait jouer l’oncologue dans l’adhĂ©sion du patient Ă  la dĂ©marche. L’étude PROPOUMON national a confirmĂ© la reproductibilitĂ© du dispositif dans d’autres hĂŽpitaux et son efficacitĂ© pour repĂ©rer les expositions professionnelles. Nos donnĂ©es suggĂšrent un effet de l’exposition professionnelle Ă  l’amiante sur la survie bien que les rĂ©sultats ne soient pas significatifs. Ce travail a Ă©valuĂ© un dispositif de repĂ©rage systĂ©matique des expositions professionnelles chez les patients avec un cancer du poumon, qui pourrait ĂȘtre intĂ©grĂ© dans le parcours de soins. Des travaux devront ĂȘtre menĂ©s pour renforcer l’adhĂ©sion au dispositif. Une rĂ©flexion sur son financement est importante pour le pĂ©renniser. Le rĂŽle potentiel des expositions professionnelles sur le pronostic des cancers renforce la nĂ©cessitĂ© d’un repĂ©rage systĂ©matique

    Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort

    No full text
    Occupational lung cancers are under-reported and under-compensated worldwide. We assessed systematic screening for occupational exposure to carcinogens combining a self-administered questionnaire and an occupational consultation to improve the detection of occupational lung cancers and their compensation. Social deprivation and the costs of this investigation were estimated. Patients with lung cancer received a self-administered questionnaire to collect their job history, potential exposure to carcinogens and deprivation. A physician assessed the questionnaire and recommended an occupational consultation if necessary. During the consultation, a physician assessed if the lung cancer was work-related and, if it was, delivered a medical certificate to claim for compensation. Over 18 months, 440 patients received the self-administered questionnaire: 234 returned a completed questionnaire and a consultation was required for 120 patients. Compensation was judged possible for 41 patients. Among the 35 medical certificates delivered, 19 patients received compensation. Nearly half the patients (46%) were assessed as socially deprived and these patients took significantly longer to return the questionnaire compared with those who were not deprived. The mean cost of the process was €62.65 per patient. Our results showed a systematic self-administered questionnaire can be used to identify patients potentially exposed to carcinogens and to improve compensation

    Development of a software based on automatic multi-temporal aerial images classification to assess retrospective environmental exposures to pesticides in epidemiological studies

    No full text
    National audienceEnvironmental exposure to agricultural pesticides (EEAP) resulting from the drift of agricultural pesticides applied on fields and is suspected to be a risk factor for several diseases. Geographic Information Systems (GIS) are increasingly used in environmental epidemiological studies to assess EEAP. Crop acreage proximate to subjects residences has been suggested as a surrogate for EEAP. Retrospective characterization of EEAP is essential due to long latency. Earlier data are lacking and limitting the capacity to capture the life-course effects of exposure. We aimed to develop an innovative software to analyze the historical monochromatic aerial images to reconstruct land use to characterize EEAP retrospectively

    Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial

    No full text
    International audienceAbstract Background Patients with a metastatic breast cancer suffer from a deteriorated health-related quality of life and numerous symptoms such as pain, severe fatigue and a decrease of their physical fitness. As the feasibility of a physical activity program has been demonstrated in this population, ABLE02 aims to assess the efficacy of a 6 month-physical activity program using connected devices to improve health-related quality of life and to reduce fatigue in women with metastatic breast cancer. Methods ABLE02 is a prospective, national, multicenter, randomized, controlled and open-label study. A total of 244 patients with a metastatic breast cancer, with at least one positive hormone receptor and a first-line chemotherapy planned, will be randomly assigned (1:1 ratio) to: (i) the intervention arm to receive physical activity recommendations, an activity tracker to wear 24 h a day during the whole intervention (6 months) with at least three weekly walking sessions and quizzes each week on physical activity and nutrition (ii) the control arm to receive physical activity recommendations only. Health-related quality of life will be assessed every 6 weeks and main assessments will be conducted at baseline, M3, M6, M12 and M18 to evaluate the clinical, physical, biological and psychological parameters and survival of participants. All questionnaires will be completed on a dedicated application. Discussion An activity program based on a smartphone application linked to an activity tracker may help to improve quality of life and reduce fatigue of patients with a metastatic breast cancer. The growth of e-health offers the opportunity to get real-time data as well as improving patient empowerment in order to change long-term behaviors. Trial registration NCT number: NCT04354233

    Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial

    No full text
    International audienceIntroduction Patients with metastatic non-small cell lung cancer (mNSCLC) suffer from numerous symptoms linked to disease and treatment which may further impair the patient’s overall condition. In addition to its benefits on quality of life and fatigue, physical exercise may improve treatment response, notably due to its known effects on the immune system. The ERICA study is designed to assess the feasibility of a supervised acute physical exercise therapy realised immediately prior immune-chemotherapy infusion in patients with mNSCLC. Secondary objectives will examine the effects of acute exercise combined with an unsupervised home-walking programme on clinical, physical, psychosocial and biological parameters. Methods and analysis ERICA is a prospective, monocentric, randomised controlled, open-label feasibility study conducted at the Centre LĂ©on BĂ©rard Comprehensive Cancer Center (France). Thirty patients newly diagnosed with mNSCLC will be randomised (2:1 ratio) to the ‘exercise’ or the ‘control’ group. At baseline and during the last treatment cycle, participants in both groups will receive Physical Activity recommendations, and two nutritional assessments. In the exercise group, participants will receive a 3-month programme consisting of a supervised acute physical exercise session prior to immune-chemotherapy infusion, and an unsupervised home-based walking programme with an activity tracker. The acute exercise consists of 35 min interval training at submaximal intensity scheduled to terminate 15 min prior to infusion. Clinical, physical, biological and psychosocial parameters will be assessed at baseline, 3 and 6 months after inclusion. Biological measures will include immune, inflammatory, metabolic, oxidative stress biomarkers and molecular profiling. Ethics and dissemination The study protocol was approved by the French ethics committee (ComitĂ© de protection des personnes Ile de France II, N°ID-RCB 20.09.04.65226, 8 December 2020). The study is registered on ClinicalTrials.gov (NCT number: NCT04676009 ) and is at the pre-results stage. All participants will sign an informed consent form. The findings will be disseminated in peer-reviewed journals and academic conferences

    Évaluation d’un auto-questionnaire de repĂ©rage des expositions professionnelles chez les patients atteints de cancer bronchopulmonaire

    No full text
    International audienceTen to 29% of lung cancers might be linked to occupational factors but 60% of them are not compensated. The PROPOUMON project aimed to improve the identification, recognition and compensation of occupational lung cancer as occupational disease using a self-administered questionnaire (AQREP). One objective was to assess the AQREP, comparing it with the questionnaire drawn up by the French Language Pneumology Society (Q-SPLF). From March 2014 to September 2015, 90 lung cancer patients treated at the Centre LĂ©on-BĂ©rard responded to the AQREP and Q-SPLF. The two physicians in charge of the consultation assessed independently whether or not a consultation was indicated. A certificate for the compensation process was proposed when a suspicion of high or average imputability was identified. Analysis of the questionnaires was concordant for 73% of the patients. The AQREP has a sensitivity of 72% and a specificity of 73%. Its positive and negative predictive values were 62 and 82%. The information provided by 24 patients were discordant between questionnaires. In two patients with discordant evaluation (AQREP+/Q-SPLF-; AQREP-/Q-SPLF+), one Initial Medical Certificate (IMC) was written. This study made it possible to conclude that AQREP is relevant for the identification of potentially occupational lung cancers. Collegial discussion of complex cases might be considered. The project is currently been extended to other centers and to lymphoma.Dix Ă  29 % des cancers bronchopulmonaires seraient d’origine professionnelle dont 60 % ne seraient pas indemnisĂ©s. Le projet Propoumon vise Ă  amĂ©liorer le repĂ©rage, la reconnaissance et l’indemnisation des cancers bronchopulmonaires d’origine professionnelle en maladie professionnelle Ă  partir d’un auto-questionnaire (AQREP). Un des objectifs Ă©tait d’évaluer sa capacitĂ© Ă  dĂ©tecter les patients pouvant bĂ©nĂ©ficier d’une consultation « cancers professionnels », en le comparant avec le questionnaire de la SociĂ©tĂ© de pneumologie de langue française (Q-SPLF). De mars 2014 Ă  septembre 2015, 90 patients suivis au centre LĂ©on-BĂ©rard pour un cancer bronchopulmonaire ont rĂ©pondu aux deux questionnaires. Les deux mĂ©decins responsables de la consultation Ă©valuaient de façon indĂ©pendante, sur la base de l’AQREP ou du Q-SPLF, l’indication d’une consultation. Si Ă  l’issue de la consultation des arguments en faveur d’une origine professionnelle Ă©taient rĂ©unis, une dĂ©marche de dĂ©claration Ă©tait proposĂ©e. L’analyse des questionnaires par les mĂ©decins Ă©tait concordante Ă  73 %. L’AQREP a une sensibilitĂ© de 72 % et une spĂ©cificitĂ© de 73 %. Ses valeurs prĂ©dictives positive et nĂ©gative sont de 62 et 82 %. Les informations renseignĂ©es par 24 patients Ă©taient discordantes entre les questionnaires. Pour deux patients ayant une Ă©valuation discordante (AQREP+/Q-SPLF- ; AQREP-/Q-SPLF+), un « Certificat mĂ©dical initial » a Ă©tĂ© rĂ©digĂ©. Le premier a Ă©tĂ© refusĂ© par l’Assurance maladie, le second est en cours d’instruction. Cette Ă©tude a permis de conclure en la capacitĂ© de l’AQREP Ă  repĂ©rer les cancers bronchopulmonaires potentiellement d’origine professionnelle. Une rĂ©union de concertation pour discuter des cas complexes pourrait ĂȘtre envisagĂ©e. Le projet s’élargit actuellement Ă  d’autres centres et aux lymphomes

    Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France

    No full text
    International audienceAbstract While head and neck cancer incidence decreased worldwide due to reduced tobacco and alcohol consumption, oral tongue cancer (OTC) incidence has been reported to be increasing in several countries. Our study examines the incidence trends of OTC in France from 1990 to 2018, globally and by age; and compares the incidence trends with the evolution of the incidence of other human papilloma virus‐unrelated head and neck squamous cell carcinoma, that is, cancers of the remaining subsites of the oral cavity (RSOCC) and laryngeal cancers for the period 1990 to 2018. World age‐standardized incidence rates of oral tongue cancers ( C02 ), cancers of the remaining subsites of the oral cavity (RSOCC, C03‐06 ) and laryngeal cancers ( C32 ) were estimated using the French National Network of Cancer Registries for the period 1990 to 2018. Trends in national incidence rates were estimated from a mixed‐effect Poisson model including age and year effects using penalized splines and a district‐random effect. In women aged 30 and 40, a significant increase in OTC incidence was observed, while ROSCC showed a nonsignificant incidence decrease. In young men aged 25, a marginally significant increase of OTC incidence years was observed, while incidence rates of RSOCC significantly declined. The results suggest a tendency towards diverging incidence trends for OTC compared to RSOCC and laryngeal cancer in young adults. The observed trends may reflect changes in underlying exposures or emerging exposures not yet identified, and stress the need to further investigate the etiology of oral tongue cancers
    corecore